Details for Patent: 9,907,793
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,907,793 protect, and when does it expire?
Patent 9,907,793 protects TARGINIQ and is included in one NDA.
This patent has one hundred and thirty-five patent family members in thirty-two countries.
Summary for Patent: 9,907,793
Title: | Pharmaceutical preparation containing oxycodone and naloxone |
Abstract: | The invention concerns a storage stable pharmaceutical preparation comprising oxycodone and naloxone for use in pain therapy, with the active compounds being released from the preparation in a sustained, invariant and independent manner. |
Inventor(s): | Brogmann; Bianca (Ulm, DE), Muhlau; Silke (Biberach, DE), Spitzley; Christof (Elbtal, DE) |
Assignee: | Purdue Pharma L.P. (Stamford, CT) |
Application Number: | 15/399,487 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,907,793
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-001 | Jul 23, 2014 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | See Plans and Pricing | |||
Purdue Pharma Lp | TARGINIQ | naloxone hydrochloride; oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 205777-002 | Jul 23, 2014 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | MANAGEMENT OF PAIN SEVERE ENOUGH TO REQUIRE DAILY, AROUND-THE-CLOCK, LONG-TERM OPIOID TREATMENT AND FOR WHICH ALTERNATIVE TREATMENT OPTIONS ARE INADEQUATE | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,907,793
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 102 15 067 | Apr 5, 2002 |
Germany | 102 15 131 | Apr 5, 2002 |
International Family Members for US Patent 9,907,793
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 2043 | See Plans and Pricing | |||
African Regional IP Organization (ARIPO) | 2397 | See Plans and Pricing | |||
Argentina | 039378 | See Plans and Pricing | |||
Argentina | 039379 | See Plans and Pricing | |||
Argentina | 090677 | See Plans and Pricing | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |